Teams
Annoviant, Inc.
from Clemson University.Annoviant is advancing patient outcomes in heart disease by delivering innovative, regenerative cardiovascular devices built on its proprietary TxGuard™ soft-tissue technology.
The platform enables durable, off-the-shelf…
Avast Therapeutics
from University of Kentucky.Avast Therapeutics is developing first-in-class, non-invasive peptide therapeutics that safely cross the blood-brain barrier to restore mitochondrial function and protect neurons.
This…
Bluegrass Pharmaceuticals Inc.
from University of Kentucky.Bluegrass Pharmaceuticals develops advanced Lipid Nanoparticles (LNPs) to enhance vaccine efficacy and enable targeted therapeutic delivery.
Kifa Therapeutics, Inc.
from Vanderbilt University.Kifa Therapeutics advances highly selective CNS-kinase inhibitors, starting with a G2019S-LRRK2 therapy for Parkinson’s disease.
Our strategy pairs genetics-based patient selection with…
Nemea Therapeutics
Nemea Therapeutics is a preclinical-stage company developing oral small molecule inhibitors targeting mitochondrial RNA polymerase (POLRMT) for the treatment of mitochondria-dependent solid tumors.
…
Moonlight Therapeutics, Inc.
Moonlight Therapeutics is a clinical-stage biotech company developing MOON101, a novel microneedle stamp treatment for peanut allergy that delivers allergen proteins directly into the skin to safely desensitize the immune system…
Myosin Therapeutics
from University of Florida.At Myosin Therapeutics, we’re tackling aggressive, treatment-resistant cancers by targeting a completely new frontier in cancer biology—the molecular nanomotors that power cancer cell movement, invasion, and…
Nutrivert Inc.
from Auburn University.Nutrivert is developing an entirely new class of medicine: an inflammation-sparing NOD2 agonist that delivers broad-spectrum, host-directed pre-exposure prophylaxis against viral diseases.
PHIOGEN
PHIOGEN is a preclinical-stage biotechnology company pioneering a next-generation phage platform to treat and prevent drug-resistant and recurrent bacterial infections.
SelSym Biotech
SelSym Biotech is pioneering hemostasis with SymClot, an innovative platelet-mimetic therapy that promises to dramatically improve patient survival and outcomes by rapidly stopping bleeding after severe trauma and high-risk…
Terra Bioforge
from Auburn University.Terra Bioforge is a microbial strain engineering company leveraging next-generation synthetic biology tools to overexpress genetically encoded bioactive compounds for multibillion-dollar pharmaceutical and agrichemical markets.
With…
